跳到正文
原文
MedPage Today·· 14 天前AI 评分45

全球2.64亿人患胆囊和胆道疾病;Amitriptyline治疗IBS;大肠息肉相关研究

146K Gallbladder, Biliary Disease Deaths; Amitriptyline for IBS; Large Rectal Polyps

AI 导读

研究显示全球2.64亿人患有胆囊和胆道疾病,导致14.6万死亡;Amitriptyline可能预测IBS对低剂量治疗的反应;JAK抑制剂与免疫介导疾病中严重感染风险增加相关。

正文

— News and commentary from the world of gastroenterology and hepatology

by Ian Ingram, Managing Editor, MedPage Today

November 5, 2026 • 2 min read

More than 264 million people globally had gallbladder and biliary diseases such as cholelithiasis, cholecystitis, or cholangitis in 2023, with the diseases together contributing to over 146,000 deaths. (Lancet Gastroenterology & Hepatology)

Are non-invasive tests in metabolic dysfunction-associated steatotic liver disease ready for prime time? (The Lancet)

A case study detailed the successful gene correction of a 66-year-old man with severe alpha-1 antitrypsin deficiency, a congenital metabolic disorder that leads to liver damage via accumulation of misfolded protein. (Journal of Hepatology)

Global liver societies including the American Association for the Study of Liver Diseases (AASLD) issued consensus definitions for acute-on-chronic liver failure. (Hepatology)

Speaking of AASLD, Hepatology introduced the group's 78th president: Michael Ronan Lucey, MD, of the University of Wisconsin in Madison.

Less than a fourth of Medicaid beneficiaries with hepatitis C received treatment within 6 months of testing, an HHS Office of Inspector General report found.

Experts issued recommendations for managing small intestinal bacterial overgrowth in pediatric short bowel syndrome and reviewed the diagnosis and management of acute cholangitis and idiosyncratic drug-induced liver injury. (JAMA Network Open, JAMA Surgery, JAMA)

Can certain gastrointestinal and psychological symptom profiles in irritable bowel syndrome (IBS) predict response to low-dose amitriptyline? (Clinical Gastroenterology and Hepatology)

Researchers from Norway linked inflammatory bowel disease (IBD) diagnoses with an increased risk of needing work disability benefits. (Inflammatory Bowel Diseases)

JAK inhibitors were associated with a higher risk of serious infections versus anti-interleukin (IL)-23 or -IL-12/23 blockers in older patients with immune-mediated diseases including IBD. (Clinical Gastroenterology and Hepatology)

Real-world data in ulcerative colitis showed higher clinical remission rates with ustekinumab (Stelara) as first- or second-line therapy compared with TNF inhibitors or vedolizumab (Entyvio), while upadacitinib (Rinvoq) had the highest rates in patients previously exposed to biologics. (Inflammatory Bowel Diseases)

In patients who underwent endoscopic mucosal resections for large colorectal polyps, rectal lesions were linked to a higher likelihood of invasive cancer and recurrence compared with colonic lesions, a retrospective cohort study from Poland found. (Gut)

Meanwhile, the level of risk for post-operative metachronous advanced colorectal neoplasia in early-onset colorectal cancer doesn't support increased surveillance efforts in this patient population, according to research in the American Journal of Gastroenterology.

来源:MedPage Today · medpagetoday.com